IRONWOOD PHARMACEUTICALS, INC. Zu einer Liste hinzufügen
Finanzielle Vergleiche Ironwood Pharmaceuticals, Inc.
Aktien
A0X789
US46333X1081
IRWD
Biotechnologie
|
Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
| 4.235 USD | +3.80% |
|
-14.82% | -63.07% |
Hauptkonkurrenten
Zu einer Liste hinzufügen 0 ausgewählt | Umsatz ($) (Y-1) | Nettomarge (Y-1) | Umsatzrendite (Y-1) | ROE (Y-1) | ROA (Y-1) | Verschuldungsgrad (Verbindlichkeiten / EBITDA) (Y-1) | |
|---|---|---|---|---|---|---|---|
| 443 Mio. | -226,37% | -213,54% | - | - | - | ||
| 7.93 Mrd. | +9,74% | +13,98% | +6,52% | +3,82% | 0.46x | ||
| 14.98 Mrd. | +9,06% | +20,36% | +32,01% | +5,22% | 3.45x | ||
| 1.83 Mrd. | -24,08% | -15,43% | - | -11,94% | 0.17x | ||
| 6.85 Mrd. | -68,84% | -61,90% | -28,59% | -21,29% | 2.38x | ||
| 1.62 Mrd. | +24,61% | +29,93% | +5,07% | +4,31% | 1.46x | ||
| 8.12 Mrd. | +7,54% | +19,31% | +6,90% | +3,58% | 2x | ||
| 2.33 Mrd. | +42,31% | +50,91% | +18,27% | +14,91% | -1.85x | ||
| 1.16 Mrd. | +14,50% | +31,94% | +14,11% | +6,29% | 0.4x | ||
| 1.97 Mrd. | +17,37% | +26,90% | +4,69% | +2,75% | 0.69x | ||
| 1.89 Mrd. | +15,00% | +17,94% | +59,83% | +18,80% | -0.29x | ||
| 4.13 Mrd. | +11,49% | +20,31% | +16,70% | +6,95% | 2.34x | ||
| 11.58 Mio. | -3.768,28% | -4.207,12% | -34,76% | -30,38% | 3.85x | ||
| 532 Mio. | -40,26% | - | - | - | - | ||
| 682 Mio. | +19,38% | +22,41% | +9,00% | - | -1.79x | ||
| 788 Mio. | -46,45% | -44,80% | -76,34% | -13,26% | 3.21x | ||
| 1.04 Mrd. | +27,44% | +35,35% | +9,95% | +7,09% | -1.51x | ||
| 249 Mio. | -203,30% | -194,99% | -157,13% | - | 0.99x | ||
| 1.62 Mrd. | +13,88% | +14,92% | +13,86% | +6,82% | 1.36x | ||
| Durchschnitt | 3.06 Mrd. | -219.22% | -246.31% | -6.24% | +0.25% | 1.02x | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 5.47 Mrd. | -90.00% | -93.69% | +3.71% | -0.22% | 1.27x |
- Börse
- Aktien
- A0X789 Aktie
- Sektor Ironwood Pharmaceuticals, Inc.
- Finanzielle Vergleiche
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben